Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment

被引:63
作者
Chiarella, Anna M. [1 ]
Ryu, Yun K. [2 ]
Manji, Gulam A. [1 ,2 ]
Rustgi, Anil K. [1 ]
机构
[1] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Div Digest & Liver Dis, Dept Med,Vagelos Coll Phys & Surg,Irving Med Ctr, New York, NY 10032 USA
[2] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Div Hematol Oncol, Dept Med,Vagelos Coll Phys & Surg,Irving Med Ctr, New York, NY 10032 USA
来源
TRENDS IN CANCER | 2021年 / 7卷 / 08期
基金
美国国家卫生研究院;
关键词
REGULATORY T-CELLS; NUCLEOSIDE TRANSPORTER FAMILIES; ECTO-5'-NUCLEOTIDASE CD73; RECEPTOR EXPRESSION; SUPPRESSOR-CELLS; TUMOR-GROWTH; FIND-ME; PATHWAY; CD39; NUCLEOTIDES;
D O I
10.1016/j.trecan.2021.04.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ATP hydrolysis and downstream signaling pathways in the extracellular space have a major impact upon tumor progression and metastasis. The complexity and interdependence of various cell types in the extracellular space have been increasingly appreciated in recent years. With increased awareness of the importance of this signaling pathway in the pathogenic development and progression of malignancies, there has been attention to therapeutic strategies targeting extracellular adenosine metabolism and signaling. This review summarizes the molecular and physiologic roles of extracellular ATP and adenosine in normal and disease states, and potential therapeutic applications.
引用
收藏
页码:731 / 750
页数:20
相关论文
共 151 条
[1]   Ectonucleoside triphosphate diphosphohydrolase-1 (E-NTPDase1/CD39) as a new prognostic marker in chronic lymphocytic leukemia [J].
Abousamra, Nashwa Khairat ;
El-Din, Manal Salah ;
Elzahaf, Eman Hamza ;
Esmael, Mohammed Ebrahim .
LEUKEMIA & LYMPHOMA, 2015, 56 (01) :113-119
[2]  
Allard B, 2020, NAT REV CLIN ONCOL, V17, P611, DOI 10.1038/s41571-020-0382-2
[3]   The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases [J].
Antonioli, Luca ;
Blandizzi, Corrado ;
Pacher, Pal ;
Hasko, Gyorgy .
PHARMACOLOGICAL REVIEWS, 2019, 71 (03) :345-382
[4]   Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities [J].
Antonioli, Luca ;
Yegutkin, Gennady G. ;
Pacher, Pal ;
Blandizzi, Corrado ;
Hasko, Gyorgy .
TRENDS IN CANCER, 2016, 2 (02) :95-109
[5]   CD39 and CD73 in immunity and inflammation [J].
Antonioli, Luca ;
Pacher, Pal ;
Vizi, E. Sylvester ;
Hasko, Gyoergy .
TRENDS IN MOLECULAR MEDICINE, 2013, 19 (06) :355-367
[6]   The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence [J].
Barker, Holly E. ;
Paget, James T. E. ;
Khan, Aadil A. ;
Harrington, Kevin J. .
NATURE REVIEWS CANCER, 2015, 15 (07) :409-425
[7]   Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity [J].
Bastid, Jeremy ;
Regairaz, Anne ;
Bonnefoy, Nathalie ;
Dejou, Cecile ;
Giustiniani, Jerome ;
Laheurte, Caroline ;
Cochaud, Stephanie ;
Laprevotte, Emilie ;
Funck-Brentano, Elisa ;
Hemon, Patrice ;
Gros, Laurent ;
Bec, Nicole ;
Larroque, Christian ;
Alberici, Gilles ;
Bensussan, Armand ;
Eliaou, Jean-Francois .
CANCER IMMUNOLOGY RESEARCH, 2015, 3 (03) :254-265
[8]   CD38 in cancer-associated fibroblasts promotes pro-tumoral activity [J].
Ben Baruch, Bar ;
Mantsur, Einav ;
Franco-Barraza, Janusz ;
Blacher, Eran ;
Cukierman, Edna ;
Stein, Reuven .
LABORATORY INVESTIGATION, 2020, 100 (12) :1517-1531
[9]   ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment [J].
Bianchi, G. ;
Vuerich, M. ;
Pellegatti, P. ;
Marimpietri, D. ;
Emionite, L. ;
Marigo, I. ;
Bronte, V. ;
Di Virgilio, F. ;
Pistoia, V. ;
Raffaghello, L. .
CELL DEATH & DISEASE, 2014, 5 :e1135-e1135
[10]   Adenosine Metabolism: Emerging Concepts for Cancer Therapy [J].
Boison, Detlev ;
Yegutkin, Gennady G. .
CANCER CELL, 2019, 36 (06) :582-596